| # | % | |||||
|---|---|---|---|---|---|---|
| 251 | LEXICON PHARMACEUTICALS INC | 4,092 | 4,890,000 | 0.24% | Call | |
| 252 | RETROPHIN INC | 3,617 | 4,941,000 | 0.25% | Call | |
| 253 | ARBUTUS BIOPHARMA CORP | 1,197,338 | 4,945,000 | 0.25% | ||
| 254 | ACADIA PHARMACEUTICALS INC | 1,840 | 5,145,000 | 0.26% | Call | |
| 255 | BLUEPRINT MEDICINES CORP | 3,000 | 5,415,000 | 0.27% | Call | |
| 256 | TENAX THERAPEUTICS INC | 2,771,109 | 5,681,000 | 0.28% | ||
| 257 | BIOMARIN PHARMACEUTICAL INC 0.75 10/15/2018 | 5,000,000 | 5,794,000 | 0.29% | PRN | |
| 258 | DEPOMED INC | 4,208 | 5,862,000 | 0.29% | Call | |
| 259 | ANACOR PHARMACEUTICALS INC | 1,214 | 6,489,000 | 0.32% | Call | |
| 260 | GW PHARMACEUTICALS PLC | 908 | 6,551,000 | 0.33% | Put | |
| 261 | PORTOLA PHARMACEUTICALS INC | 3,221 | 6,571,000 | 0.33% | Call | |
| 262 | LINKEDIN CORP | 579 | 6,621,000 | 0.33% | Call | |
| 263 | EXPRESS SCRIPTS HLDG CO | 1,064 | 7,309,000 | 0.37% | Put | |
| 264 | REGULUS THERAPEUTICS INC | 11,703 | 8,110,000 | 0.41% | Call | |
| 265 | UNITED THERAPEUTICS CORP | 750 | 8,357,000 | 0.42% | Call | |
| 266 | RETROPHIN INC | 6,251 | 8,539,000 | 0.43% | Put | |
| 267 | ACORDA THERAPEUTICS INC | 9,600,000 | 8,580,000 | 0.43% | PRN | |
| 268 | ABBVIE INC | 1,546 | 8,831,000 | 0.44% | Put | |
| 269 | GLOBAL BLOOD THERAPEUTICS INC | 5,627 | 8,924,000 | 0.45% | Call | |
| 270 | BIOGEN INC | 37,077 | 9,652,000 | 0.48% | ||
| 271 | SAREPTA THERAPEUTICS INC | 505,937 | 9,876,000 | 0.49% | ||
| 272 | REGENERON PHARMACEUTICALS | 39,027 | 14,067,000 | 0.70% | ||
| 273 | CYTORI THERAPEUTIC INC | 7,305,690 | 14,310,000 | 0.72% | ||
| 274 | SAREPTA THERAPEUTICS INC | 8,824 | 17,224,000 | 0.86% | Put | |
| 275 | EDWARDS LIFESCIENCES CORP | 2,201 | 19,415,000 | 0.97% | Put | |
| 276 | REGENERON PHARMACEUTICALS | 588 | 21,194,000 | 1.06% | Put | |
| 277 | AMGEN INC | 143,486 | 21,513,000 | 1.08% | ||
| 278 | EDWARDS LIFESCIENCES CORP | 2,477 | 21,850,000 | 1.09% | Call | |
| 279 | JOHNSON & JOHNSON | 2,061 | 22,300,000 | 1.12% | Put | |
| 280 | SPDR S&P 500 ETF TR | 108,899 | 22,385,000 | 1.12% | ||
| 281 | BIOGEN INC | 1,052 | 27,386,000 | 1.37% | Put | |
| 282 | SPDR SERIES TRUST | 5,337 | 27,571,000 | 1.38% | Put | |
| 283 | MEDICINES CO | 9,501 | 30,185,000 | 1.51% | Call | |
| 284 | LILLY ELI & CO | 4,803 | 34,586,000 | 1.73% | Put | |
| 285 | AMGEN INC | 3,441 | 51,591,000 | 2.58% | Put | |
| 286 | HCA HOLDINGS INC | 6,798 | 53,058,000 | 2.65% | Call | |
| 287 | Call JNJ $125.0 Exp May 19, 2017 | 6,374 | 68,967,000 | 3.45% | Call | |
| 288 | Call GILD $70.0 Exp Jun 16, 2017 | 8,440 | 77,530,000 | 3.88% | Call | |
| 289 | ABBVIE INC | 13,966 | 79,774,000 | 3.99% | Call | |
| 290 | ISHARES TR | 17,673 | 162,342,000 | 8.12% | Put | |
| 291 | BIOGEN INC | 6,663 | 173,451,000 | 8.68% | Call | |
| 292 | IMMUNOMEDICS INCORPORATED | 2,680,000 | 182,240,000 | 9.12% | PRN | |
| 293 | SPDR S&P 500 ETF TR PUT | 10,176 | 188,635,000 | 9.44% | Put | |
| 294 | LILLY ELI & CO | 28,962 | 208,555,000 | 10.43% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-101848, filed 2016.05.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
